Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Meanwhile AKRO.....a 2B$ company

<< Previous

Bullboard Posts

Next >>

Comment by Biobobon Oct 07, 2022 12:45pm

105 Views

Post# 35012568

RE:RE:RE:RE:RE:RE:RE:Meanwhile AKRO.....a 2B$ company

Nash/Nothing, Legacy sales/Price inceases mostly, Th1902/Slow progress and no tangible value atm, Valuation is still mediocre, same CFO, no worthy anayst still, IR answering machine instead of engaging conversation. Anyway let's wait and see if he can descend upon us next week... alleluia..

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing